Biography
Dr Tsai strives to provide compassionate, expert, evidence-based care for all patients. She works closely with plastic and reconstructive surgeons to help patients achieve both the optimal oncologic surgery as well as the desired cosmetic outcomes that patients desire. She is also involved in clinical trials that aim to improve diagnostic and therapeutic interventions for patients with breast cancer.
Professional Summary
Education & Certifications
- Board Certification: American Board of Surgery, General Surgery (2019)
- Fellowship: Stanford Hospital and Clinics - Dept of Surgery (2016) CA
- Residency: Albert Einstein College of Medicine Montefiore Medical Center (2015) NY
- Medical Education: Rutgers New Jersey Medical School Office of the Registrar (2008) NJ
Publications
-
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
Tsai, J., Bertoni, D., Hernandez-Boussard, T., Telli, M. L., & Wapnir, I. L. (2016). Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer. Annals of Surgical Oncology, 23(10), 3310–16. -
Pathological confirmation of pre-chemotherapy biopsied and tattooed axillary lymph nodes
Patel, R., MacKerricher, W., Tsai, J., Wood, L., Allison, K., & Wapnir, I. (2018). Pathological confirmation of pre-chemotherapy biopsied and tattooed axillary lymph nodes. ANNALS OF SURGICAL ONCOLOGY, 25, 426–27. -
Disease-Free Survival Using Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy
Tsai, J., Bertoni, D., Tsai, C. Y., Hernandez-Boussard, T., & Wapnir, I. (2016). Disease-Free Survival Using Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy. ANNALS OF SURGICAL ONCOLOGY, 23, 162–63. -
Internal hernia associated with perforated Meckel's diverticulum
Hui, V. W., Tsai, J., Gokarn, N., & Statter, M. B. (2016). Internal hernia associated with perforated Meckel's diverticulum. JOURNAL OF PEDIATRIC SURGERY CASE REPORTS, 4, 52–53. -
Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
Patel, R., MacKerricher, W., Tsai, J., Choy, N., Lipson, J., Ikeda, D., … Wapnir, I. L. (2019). Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node. Annals of Surgical Oncology. -
Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node
Patel, R., MacKerricher, W., Tsai, J., Choy, N., Lipson, J., Ikeda, D., … Wapnir, I. L. (2019). Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node. ANNALS OF SURGICAL ONCOLOGY, 26(8), 2452–58. -
The Impact of Device Innovation on Clinical Outcomes in Expander-based Breast Reconstruction
Momeni, A., Li, A. Y., Tsai, J., Wan, D., Karin, M. R., & Wapnir, I. L. (2019). The Impact of Device Innovation on Clinical Outcomes in Expander-based Breast Reconstruction. PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 7(12). -
A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS)
Wapnir, I., DeMartini, W., Allison, K., Stone, K., Dirbas, F., Marquez, C., … Horst, K. (2020). A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS). CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
The Impact of Device Innovation on Clinical Outcomes in Expander-based Breast Reconstruction.
Momeni, A., Li, A. Y., Tsai, J., Wan, D., Karin, M. R., & Wapnir, I. L. (2019). The Impact of Device Innovation on Clinical Outcomes in Expander-based Breast Reconstruction. Plastic and Reconstructive Surgery. Global Open, 7(12), e2524. -
Surgical excision of BioZorb device eroding through the nipple-areolar complex one year postoperatively: A case report.
Ju, T., & Tsai, J. (2021). Surgical excision of BioZorb device eroding through the nipple-areolar complex one year postoperatively: A case report. The Breast Journal. -
Feasibility of Lumpectomy Surgery for Large Ductal Carcinoma In Situ
Edquilang, J., Tsai, J., Park, Y., & Wapnir, I. (2020). Feasibility of Lumpectomy Surgery for Large Ductal Carcinoma In Situ. ANNALS OF SURGICAL ONCOLOGY, 27(SUPPL 2), S333. -
Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss
Ju, T., Momeni, A., Gurtner, G., Nguyen, D., & Wapnir, I. (2021). Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss. ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Are We Over-Imaging the Axilla in Patients Undergoing Neoadjuvant Chemotherapy?
Tsai, J. (2021). Are We Over-Imaging the Axilla in Patients Undergoing Neoadjuvant Chemotherapy? ANNALS OF SURGICAL ONCOLOGY, 28(SUPPL 2), S305–S306. -
Two-Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss.
Ju, T., Chandler, J., Momeni, A., Gurtner, G., Tsai, J., Nguyen, D., & Wapnir, I. (2021). Two-Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss. Annals of Surgical Oncology. -
Correction to: Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss.
Ju, T., Chandler, J., Momeni, A., Gurtner, G., Tsai, J., Nguyen, D., & Wapnir, I. (2021). Correction to: Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss. Annals of Surgical Oncology. -
ASO Visual Abstract: Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss.
Ju, T., Chandler, J., Momeni, A., Gurtner, G., Tsai, J., Nguyen, D., & Wapnir, I. (2021). ASO Visual Abstract: Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss. Annals of Surgical Oncology. -
Influence of Imaging Features and Technique on US-guided Tattoo Ink Marking of Axillary Lymph Nodes Removed at Sentinel Lymph Node Biopsy in Women With Breast Cancer
Pajcini, M., Wapnir, I., Tsai, J., Edquilang, J., DeMartini, W., & Ikeda, D. (2021). Influence of Imaging Features and Technique on US-guided Tattoo Ink Marking of Axillary Lymph Nodes Removed at Sentinel Lymph Node Biopsy in Women With Breast Cancer. JOURNAL OF BREAST IMAGING, 3(5), 583–590. -
Two-stage nipple-sparing mastectomy does not compromise oncologic safety
Thompson, C., Chandler, J., Ju, T., Wapnir, I., & Tsai, J. (2022). Two-stage nipple-sparing mastectomy does not compromise oncologic safety. ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Nipple-areola-complex preservation and obesity-Successful in stages.
Daly, L., Tsai, J., Stone, K., Wapnir, I., Karin, M., Wan, D., & Momeni, A. (2023). Nipple-areola-complex preservation and obesity-Successful in stages. Microsurgery. -
Frailty Analysis and Outcomes of Breast Cancer Surgery in Elderly Patients Aged 85 and Older
Foulad, D., Wapnir, I., Xu, A., Stone, K., Dirbas, F., Karin, M., … Tsai, J. (2023). Frailty Analysis and Outcomes of Breast Cancer Surgery in Elderly Patients Aged 85 and Older. ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Age is Just a Number: A Single Institution Review of Surgical Management of Breast Cancer in Elderly Patients Aged 85 and Older
Foulad, D. S., Tsai, J., Najafzadeh, P., Allison, K., & Wapnir, I. (2023). Age is Just a Number: A Single Institution Review of Surgical Management of Breast Cancer in Elderly Patients Aged 85 and Older. ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Characteristics and Management of Breast Lesions in Elderly Patients Aged 85 and Older
Foulad, D. S., Wapnir, I., Najafzadeh, P., Allison, K., & Tsai, J. (2023). Characteristics and Management of Breast Lesions in Elderly Patients Aged 85 and Older. ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Influence of Imaging Features and Technique on US-guided Tattoo Ink Marking of Axillary Lymph Nodes Removed at Sentinel Lymph Node Biopsy in Women With Breast Cancer.
Pajcini, M., Wapnir, I., Tsai, J., Edquilang, J., DeMartini, W., & Ikeda, D. (2021). Influence of Imaging Features and Technique on US-guided Tattoo Ink Marking of Axillary Lymph Nodes Removed at Sentinel Lymph Node Biopsy in Women With Breast Cancer. Journal of Breast Imaging, 3(5), 583–590. -
Can Completion Axillary Lymph Node Dissection be Omitted after Neoadjuvant Endocrine Therapy?
Beck, A. S., Troxell, M., Tsai, J., & Wapnir, I. (2024). Can Completion Axillary Lymph Node Dissection be Omitted after Neoadjuvant Endocrine Therapy? ANNALS OF SURGICAL ONCOLOGY. SPRINGER. -
Residual cancer burden in two-stage nipple sparing mastectomy after first stage lumpectomy and devascularization of the nipple areolar complex.
Thompson, C. N., Chandler, J., Ju, T., Tsai, J., & Wapnir, I. (2024). Residual cancer burden in two-stage nipple sparing mastectomy after first stage lumpectomy and devascularization of the nipple areolar complex. Breast Cancer Research and Treatment.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Stanford Women's Cancer Center Palo Alto, CA
Palo Alto, CAStanford Women's Cancer Center
900 Blake Wilbur Drive, 1st Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereBreast Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CABreast Cancer Program in Palo Alto
900 Blake Wilbur Drive, 1st Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(55 reviews)
View More
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records